Royalty Pharma
RPRX
#995
Rank
NZ$39.59 B
Marketcap
NZ$67.89
Share price
-1.14%
Change (1 day)
55.33%
Change (1 year)

Market capitalization of Royalty Pharma (RPRX)

Market cap: NZ$39.59 Billion

As of December 2025 Royalty Pharma has a market cap of NZ$39.59 Billion. This makes Royalty Pharma the world's 995th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Royalty Pharma from 2020 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$39.59 B48.39%
2024NZ$26.68 B0.19%
2023NZ$26.63 B-3%
2022NZ$27.45 B9.57%
2021NZ$25.05 B-6.93%
2020NZ$26.92 B

End of Day market cap according to different sources

On Dec 4th, 2025 the market cap of Royalty Pharma was reported to be:

NZ$39.18 Billion
by Nasdaq info icon info icon
NZ$39.59 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ANI Pharmaceuticals
ANIP
NZ$3.22 B-91.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$378.47 B 855.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.577 T 3,883.34%๐Ÿ‡บ๐Ÿ‡ธ USA